Only Half of Patients Starting ULT After Pegloticase Discontinuation Achieved Target SU
After being prescribed another urate lowering therapy for ≥ 30 days, only 51.0% of patients were able to achieve SU < 6 mg/dL.
After being prescribed another urate lowering therapy for ≥ 30 days, only 51.0% of patients were able to achieve SU < 6 mg/dL.
Data suggest the value of performing the CDH1 test on women under age 45 years, said a researcher.
Insights on why your budget from NCCIH may be lower than what you requested and tips to help your budget submission.
Explore special articles published online first to coincide with presentations at the Combined Otolaryngology Spring Meetings.
Study of cerebral organoids reinforces evidence for substantial species barrier
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on…
In humans, the energetic cost of pregnancy is about 50,000 dietary calories — far higher than previously believed, a new study found.
Findings demonstrated a slower decline in kidney function for patients treated with sparsentan or irbesartan compared with standard of care in both real-world and clinical…
This randomized clinical trial assesses whether assisted ventilation in extremely preterm infants before umbilical cord clamping reduces intraventricular hemorrhage or early death.
Lessons learned from cohorting patients and standardizing care
This Medical News story discusses the development of experimental combination vaccines for adults.